Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Bevacizumab Mouse, Clone: 6C3, GenScript™
Mouse Monoclonal Antibody
Supplier: Genscript Corporation A0197640
Description
Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL. Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of a number of types of cancers and a specific eye disease. Bevacizumab binds a continuous epitope in VEGF, preventing interaction of VEGF with VEGFR on the surface of endothelial cells. It can be used to inhibit solid tumour growth and metastasis by weakening tumour angiogenesis.
Anti-Bevacizumab Antibody (6C3), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Bevacizumab.
Bevacizumab Monoclonal antibody specifically detects Bevacizumab in Chemical samples. It is validated for Blocking assay, ELISASpecifications
| Bevacizumab | |
| Monoclonal | |
| Unconjugated | |
| Avastin | |
| Bevacizumab | |
| 40 μg | |
| Primary | |
| Antibody | |
| IgG1 |
| Blocking Assay, ELISA | |
| 6C3 | |
| PBS with 0.02% sodium azide; pH 7.4 | |
| Mouse | |
| Protein A | |
| RUO | |
| -20°C or -80°C if preferred | |
| Lyophilized | |
| Chemical |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction